Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kevan Herold, MD
Yale University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Diabetes Center at Ucsf
San Francisco, California, United States
- Barbara Davis Center for Childhood Diabetes
Denver, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Medical College of Georgia
Augusta, Georgia, United States
- Dept. of Medicine, Division of Endocrinology and the Naomi Berrie Diabetes Center/columbia University
New York, New York, United States
- Benaroya Research Institute
Seattle, Washington, United States
- Pacific Northwest Research Institute/university of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 31 Mar 2011
- Completion
- 31 Mar 2011
- Last update posted
- 22 May 2017
- Registered enrollment
- 83
- Registry id
- NCT00129259
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.